NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of R1 RCM Inc. (“R1” or “the Company”) (NASDAQ: RCM). Investors who purchased R1 securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/RCM.
Investigation Details:
The investigation concerns whether RCM and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things:
(1) obtain the best possible consideration for RCM shareholders; and
(2) disclose all material information necessary for RCM shareholders to adequately assess and value the merger consideration.
Upon closing of the merger, R1 shareholders are expected to own approximately 70% of the combined company on a fully diluted basis while Cloudmed equity holders are expected to own approximately 30%.
What’s Next?
If you are aware of any facts relating to this investigation or purchased R1 securities, you can assist this investigation by visiting the firm’s site: bgandg.com/RCM. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Attorney advertising. Prior results do not guarantee similar outcomes.
